Therapeutic Asset Ratings
191 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Ac-Ole-09
Alzheimer Disease
Cerecin
P1
C
(37)
Ac-Ole-P
Alzheimer Disease
Cerecin
P1
C
(37)
Adel-Y01 - Mci/Ad
Alzheimer Disease
Alzheimer's Disease Expert Lab (ADEL), Inc.
P1
C
(37)
Apnmab005
Alzheimer Disease
APRINOIA Therapeutics, LLC
P1
C
(37)
av-1959d
Alzheimer Disease
Institute for Molecular Medicine
P1
C
(37)
AV-1980R
Alzheimer Disease
Institute for Molecular Medicine
P1
C
(37)
Bnh-015B
Alzheimer Disease
BnH Research
P1
C
(37)
cm383
Alzheimer Disease
Keymed Biosciences Co.Ltd
P1
C
(37)
Ddn-A-0101
Alzheimer Disease
Pharmacobio
P1
C
(37)
Donepezil Dihydroxynaphthalate For
Alzheimer Disease
Shanghai Synergy Pharmaceutical Sciences Co., Ltd.
P1
C
(37)
Dspe-Dota-Gd Liposomal
Alzheimer Disease
Alzeca Biosciences, Inc.
P1
C
(37)
Fluoroethylnormemantine
Alzheimer Disease
ReST Therapeutics
P1
C
(37)
Huc-Msc-Sev-001 Nasal Drops
Alzheimer Disease
Xuanwu Hospital, Beijing
P1
C
(37)
ion269
Alzheimer Disease
Ionis Pharmaceuticals, Inc.
P1
C
(37)
j4
Alzheimer Disease
Academia Sinica, Taiwan
P1
C
(37)
KS101
Alzheimer Disease
Klotho Sciences Australia Pty Ltd.
P1
C
(37)
ly3439539
Alzheimer Disease
Eli Lilly and Company
P1
C
(37)
ly3954068
Alzheimer Disease
Eli Lilly and Company
P1
C
(37)
ly4006895
Alzheimer Disease
Eli Lilly and Company
P1
C
(37)
nio752
Alzheimer Disease
University College, London
P1
C
(37)
Olx-07010 Active
Alzheimer Disease
Oligomerix, Inc
P1
C
(37)
Galcanezumab
Alzheimer Disease
Xuanwu Hospital, Beijing
Early P1
C
(34)
Low THC
Alzheimer Disease
Mclean Hospital
Early P1
C
(34)
NOS
Alzheimer Disease
University of Pennsylvania
Early P1
C
(34)
TEONANACATL
Alzheimer Disease
Johns Hopkins University
Early P1
C
(34)
Showing 151 to 175 of 191 assets
Previous
Page 7 of 8
Next
